Researchers are cultivating laboratory-grown human skin that can be grafted onto the body to repair defects caused by burns, surgery or disease.
While growing the thin outer skin is nothing new, the real challenge is growing the main inner skin which contains the connective tissue, including the blood vessels.
At the moment, researchers at the EU-funded EUROSKINGRAFT project can grow a seven centimetre square patch of this nearly full-thickness skin in two to four weeks.
‘The thing is we can currently do more in the lab than we are allowed to do on the patient.’
Professor Ernst Reichmann, University of Zurich, Switzerland
They do it by taking a postage stamp-sized sample of skin from the patient that will receive the graft and then cultivating it in gel.
‘I would say that these kinds of grafts can be used everywhere,’ said project coordinator Professor Ernst Reichmann, from the University of Zurich, Switzerland.
The technique has led to two potential products – denovoSkin, which contains the outer and inner layer of skin, and denovoDerm, which is just the inner layer.
Now the researchers are testing the lab-grown skin on 20 patients, and while they’ve not got the full results yet, so far the safety and clinical outcomes are ‘excellent’, according to Prof. Reichmann.
They’re hoping to start larger trials at the end of 2015, which will involve patients recruited from medical centres in Switzerland, the Netherlands and Germany.
The point of the research is that burns, surgery and diseases can damage the outer and inner layers of skin, and current techniques mean the outer layer of skin – either lab-grown or taken whole from the patient – has to be grafted to a new inner layer, which is grown on the wound.
The resulting grafted skin is marked with a criss-cross of ridges because the outer layer has to be meshed onto the inner layer – a technique that involves inserting multiple holes into the skin graft to increase its surface area and improve fluid flow.
‘With common methods the optical appearance and the pliability of the graft is not satisfying,’ Prof. Reichmann said.
By growing nearly full-thickness skin in the laboratory, the EUROSKINGRAFT researchers hope they can create smooth, soft skin grafts that look natural.
It would also help reduce one of the biggest complications with skin grafts – bacterial infection. Currently, patients are vulnerable to infection while the new inner layer of skin is forming on the wound. Removing this step, by growing full-thickness skin in the laboratory, could significantly reduce infections.
At the moment, the skin is being used to treat burns and to reduce scar tissue, but the researchers hope to extend that.
‘I think they will be beneficial for chronic ulcers and our technology can be used to help vitiligo (a disease that affects skin pigmentation) patients,’ said Prof. Reichmann. ‘There is a broad range of uses for this technology.’
In their laboratory-based work, scientists can produce skin grafts that contain pigmentation, enabling them to produce a skin colour that matches the patient, as well as a pre-formed network of capillaries.
In theory, the capillaries will increase the speed at which the skin graft connects to the underlying tissue, improving acceptance of the graft and reducing scarring.
‘The thing is, we can currently do more in the lab than we are allowed to do on the patient,’ Prof. Reichmann said.
For some people the issue of vaccination isn’t about facts, it’s a matter of faith, and this unshakable belief has become an opportunity for health workers to prepare for potential outbreaks.
Treasure troves of raw materials are resting on the ocean floor and their potential abundance is driving the emergence of deep-sea mining, and throwing up concerns about the environmental impact.
The deepest parts of the ocean were once assumed to be pristine, but recent discoveries of chemicals and radioactive products at the bottom of underwater trenches has shown that humanity’s footprint extends to the furthest reaches of the earth – and it could affect the balance of oxygen in the oceans and carbon dioxide in the atmosphere.
Rich deposits of raw materials have sparked a modern day gold rush.
Researchers believe addressing ‘anti-vaxxer’ concerns rests in cooperation, not condemnation.
Re-engineering immune cells and modifying yeast to produce drugs are just two potential applications, says Prof. Toni Cathomen.